IO / TRY

IO / USDT

IO / USDC

STORJ / USDT

STORJ / TRY

WIF / IDR

WIF / USDC

WIF / TRY

WIF / USDT

ZEC / U

HIGH / USDT

HIGH / TRY

PORTAL / USDT

PORTAL / TRY

DOGS / IDR

ONT / BTC

DOGS / USDT

DOGS / USDC

DOGS / TRY

ONT / USDT

H B ESTATE DEVELOPERS L

EMBASSY DEVELOPMENTS LTD

MEDIA MATRIX WORLDWIDE L

VISHWAS AGRI SEEDS LTD

RAYMOND REALTY LIMITED

GANDHAR OIL REFINE IND L

WOCKHARDT LIMITED

FINEOTEX CHEMICAL LIMITED

SUNFLAG IRON AND STEEL CO

BN AGROCHEM LTD.

SHILCHAR TECHNOLOGIES LTD

SAJ HOTELS LIMITED

QUALITY POWER ELEC EQUP L

DIGIKORE STUDIOS LIMITED

ADITYA INFOTECH LIMITED

VIDYA WIRES LIMITED

EFFWA INFRA & RESEARCH L

DANISH POWER LIMITED

PRECISION WIRES INDIA LTD

BHARAT BIJLEE LTD

Click here to get full coverage on Cipla Receives U.S. FDA Approval for First AB-Rated Generic of Ventolin® HFA - Yahoo Finance

Cipla Receives U.S. FDA Approval for First AB-Rated Generic of Ventolin® HFA  Yahoo Finance

Cipla Receives U.S. FDA Approval for First AB-Rated Generic of Ventolin® HFA - Yahoo Finance

Click here to get full coverage on Cipla strengthens US portfolio with the launch of generic Saxenda® (Liraglutide Injection) for weight management therapy - PR Newswire

Cipla strengthens US portfolio with the launch of generic Saxenda® (Liraglutide Injection) for weight management therapy  PR Newswire

Cipla strengthens US portfolio with the launch of generic Saxenda® (Liraglutide Injection) for weight management therapy - PR Newswire

Click here to get full coverage on India's Cipla posts steeper-than-expected quarterly profit slump on tumour drug supply crunch - Reuters

India's Cipla posts steeper-than-expected quarterly profit slump on tumour drug supply crunch  Reuters

India's Cipla posts steeper-than-expected quarterly profit slump on tumour drug supply crunch - Reuters

Click here to get full coverage on Hikma, Cipla Cut Deals In Pfizer Heart Drug Patent Case - Law360

Hikma, Cipla Cut Deals In Pfizer Heart Drug Patent Case  Law360

Hikma, Cipla Cut Deals In Pfizer Heart Drug Patent Case - Law360

Click here to get full coverage on A Litany of Errors… and Cipla’s Patent Reinstated - Pearce IP

A Litany of Errors… and Cipla’s Patent Reinstated  Pearce IP

A Litany of Errors… and Cipla’s Patent Reinstated - Pearce IP

Click here to get full coverage on FDA approves Cipla's nintedanib capsules as Ofev generic for IPF - Pulmonary Fibrosis News

FDA approves Cipla's nintedanib capsules as Ofev generic for IPF  Pulmonary Fibrosis News

FDA approves Cipla's nintedanib capsules as Ofev generic for IPF - Pulmonary Fibrosis News

Click here to get full coverage on Fennec, Cipla Resolve Patent Case Over Generic Pedmark Infusion - Bloomberg Law News

Fennec, Cipla Resolve Patent Case Over Generic Pedmark Infusion  Bloomberg Law News

Fennec, Cipla Resolve Patent Case Over Generic Pedmark Infusion - Bloomberg Law News

Click here to get full coverage on Cipla Expands U.S. Respiratory Portfolio with Approval of Nintedanib Capsules (100mg & 150mg) for Idiopathic Pulmonary Fibrosis - PR Newswire

Cipla Expands U.S. Respiratory Portfolio with Approval of Nintedanib Capsules (100mg & 150mg) for Idiopathic Pulmonary Fibrosis  PR Newswire

Cipla Expands U.S. Respiratory Portfolio with Approval of Nintedanib Capsules (100mg & 150mg) for Idiopathic Pulmonary Fibrosis - PR Newswire

Click here to get full coverage on Indian drugmaker Cipla's global CEO Umang Vohra to step down, COO to take over - Reuters

Indian drugmaker Cipla's global CEO Umang Vohra to step down, COO to take over  Reuters

Indian drugmaker Cipla's global CEO Umang Vohra to step down, COO to take over - Reuters

Click here to get full coverage on Gilead Accuses Cipla of Sidestepping Earlier Descovy Patent Deal - Bloomberg Law News

Gilead Accuses Cipla of Sidestepping Earlier Descovy Patent Deal  Bloomberg Law News

Gilead Accuses Cipla of Sidestepping Earlier Descovy Patent Deal - Bloomberg Law News

Click here to get full coverage on Cipla Expands Fall River Operations in USA, Announces Upcoming Hiring for Various Roles - PR Newswire

Cipla Expands Fall River Operations in USA, Announces Upcoming Hiring for Various Roles  PR Newswire

Cipla Expands Fall River Operations in USA, Announces Upcoming Hiring for Various Roles - PR Newswire

Click here to get full coverage on Indian drugmaker Cipla beats profit view on steady demand for respiratory drugs - Yahoo Finance

Indian drugmaker Cipla beats profit view on steady demand for respiratory drugs  Yahoo Finance

Indian drugmaker Cipla beats profit view on steady demand for respiratory drugs - Yahoo Finance

Click here to get full coverage on Eli Lilly allows Cipla to sell weight loss drug under new brand in India - Reuters

Eli Lilly allows Cipla to sell weight loss drug under new brand in India  Reuters

Eli Lilly allows Cipla to sell weight loss drug under new brand in India - Reuters

Click here to get full coverage on Cipla USA Strengthens Lung Leadership with Community Wellness Initiatives - PR Newswire

Cipla USA Strengthens Lung Leadership with Community Wellness Initiatives  PR Newswire

Cipla USA Strengthens Lung Leadership with Community Wellness Initiatives - PR Newswire

Click here to get full coverage on Cipla introduces generic Saxenda - Drug Store News

Cipla introduces generic Saxenda  Drug Store News

Cipla introduces generic Saxenda - Drug Store News

Click here to get full coverage on Sun Pharma, Cipla recall products in US over manufacturing issues: USFDA - The Economic Times

Sun Pharma, Cipla recall products in US over manufacturing issues: USFDA  The Economic Times

Sun Pharma, Cipla recall products in US over manufacturing issues: USFDA - The Economic Times

Click here to get full coverage on Cipla Health Strengthens ProlyteORS Portfolio with Launch of Masala Guava Flavour - Yahoo Finance

Cipla Health Strengthens ProlyteORS Portfolio with Launch of Masala Guava Flavour  Yahoo Finance

Cipla Health Strengthens ProlyteORS Portfolio with Launch of Masala Guava Flavour - Yahoo Finance

Click here to get full coverage on Indian drugmaker Cipla's global CEO Umang Vohra to step down, COO Gupta to take over - Yahoo Finance

Indian drugmaker Cipla's global CEO Umang Vohra to step down, COO Gupta to take over  Yahoo Finance

Indian drugmaker Cipla's global CEO Umang Vohra to step down, COO Gupta to take over - Yahoo Finance

Click here to get full coverage on Cipla Sponsors NYC Lung Force Walk - American Lung Association

Cipla Sponsors NYC Lung Force Walk  American Lung Association

Cipla Sponsors NYC Lung Force Walk - American Lung Association

Click here to get full coverage on Cipla Gets USFDA Approval for Albuterol Inhaler, Expands US Respiratory Portfolio - Medical Dialogues

Cipla Gets USFDA Approval for Albuterol Inhaler, Expands US Respiratory Portfolio  Medical Dialogues

Cipla Gets USFDA Approval for Albuterol Inhaler, Expands US Respiratory Portfolio - Medical Dialogues

Click here to get full coverage on Cipla's Goa Plant Gets 2 USFDA Observations After cGMP, Pre-Approval Inspection - Medical Dialogues

Cipla's Goa Plant Gets 2 USFDA Observations After cGMP, Pre-Approval Inspection  Medical Dialogues

Cipla's Goa Plant Gets 2 USFDA Observations After cGMP, Pre-Approval Inspection - Medical Dialogues

Click here to get full coverage on Fennec settles patent case with Cipla over generic PEDMARK - Investing.com

Fennec settles patent case with Cipla over generic PEDMARK  Investing.com

Fennec settles patent case with Cipla over generic PEDMARK - Investing.com

Click here to get full coverage on Cipla shares under pressure after USFDA import alert on key supplier - CNBC TV18

Cipla shares under pressure after USFDA import alert on key supplier  CNBC TV18

Cipla shares under pressure after USFDA import alert on key supplier - CNBC TV18

Click here to get full coverage on cipla usfda approval for albuterol sulfate inhalation aerosol us market worth 15b h1fy27 launch - ICICI Direct

cipla usfda approval for albuterol sulfate inhalation aerosol us market worth 15b h1fy27 launch  ICICI Direct

cipla usfda approval for albuterol sulfate inhalation aerosol us market worth 15b h1fy27 launch - ICICI Direct

Click here to get full coverage on Cipla Ltd. is Rated Sell by MarketsMOJO - Markets Mojo

Cipla Ltd. is Rated Sell by MarketsMOJO  Markets Mojo

Cipla Ltd. is Rated Sell by MarketsMOJO - Markets Mojo

Click here to get full coverage on Cohance Lifesciences Shares In Focus: Here's Why The Former Cipla Top Boss Is A Strategic Fit - NDTV Profit

Cohance Lifesciences Shares In Focus: Here's Why The Former Cipla Top Boss Is A Strategic Fit  NDTV Profit

Cohance Lifesciences Shares In Focus: Here's Why The Former Cipla Top Boss Is A Strategic Fit - NDTV Profit

Click here to get full coverage on Fennec Pharmaceuticals (FENC) delays Cipla generic PEDMARK rival until 2033 - Stock Titan

Fennec Pharmaceuticals (FENC) delays Cipla generic PEDMARK rival until 2033  Stock Titan

Fennec Pharmaceuticals (FENC) delays Cipla generic PEDMARK rival until 2033 - Stock Titan

Click here to get full coverage on Cipla gets 2 observations after USFDA Goa plant inspection, says will address concerns - CNBC TV18

Cipla gets 2 observations after USFDA Goa plant inspection, says will address concerns  CNBC TV18

Cipla gets 2 observations after USFDA Goa plant inspection, says will address concerns - CNBC TV18

Click here to get full coverage on "The reason we chose Cipla for partnership is that it has a strong distribution network across India. They have reach in areas we are not located. This will help us reach more patients," said Winselow Tucker of Eli Lilly and Company talking about the company's - LinkedIn

"The reason we chose Cipla for partnership is that it has a strong distribution network across India. They have reach in areas we are not located. This will help us reach more patients," said Winselow Tucker of Eli Lilly and Company talking about the company's  LinkedIn

"The reason we chose Cipla for partnership is that it has a strong distribution network across India. They have reach in areas we are not located. This will help us reach more patients," said Winselow Tucker of Eli Lilly and Company talking about the company's - LinkedIn

Click here to get full coverage on Cipla recalls over 400 cartons of cancer drug in US: FDA - The Economic Times

Cipla recalls over 400 cartons of cancer drug in US: FDA  The Economic Times

Cipla recalls over 400 cartons of cancer drug in US: FDA - The Economic Times

Click here to get full coverage on Teva Drops Cipla Qvar Inhaler Patent Row Amid FTC Delisting Push - Bloomberg Law News

Teva Drops Cipla Qvar Inhaler Patent Row Amid FTC Delisting Push  Bloomberg Law News

Teva Drops Cipla Qvar Inhaler Patent Row Amid FTC Delisting Push - Bloomberg Law News

Click here to get full coverage on Cohance Lifesciences shares skyrocket 20% on hiring former Cipla CEO Umang Vohra - The Economic Times

Cohance Lifesciences shares skyrocket 20% on hiring former Cipla CEO Umang Vohra  The Economic Times

Cohance Lifesciences shares skyrocket 20% on hiring former Cipla CEO Umang Vohra - The Economic Times

Click here to get full coverage on Cipla to Recall Lanreotide Injection in US, Temporary Supply Disruption Expected - Medical Dialogues

Cipla to Recall Lanreotide Injection in US, Temporary Supply Disruption Expected  Medical Dialogues

Cipla to Recall Lanreotide Injection in US, Temporary Supply Disruption Expected - Medical Dialogues

Click here to get full coverage on Pfizer, Cipla ink exclusive marketing, distribution pact for 4 brands - ETPharma.com

Pfizer, Cipla ink exclusive marketing, distribution pact for 4 brands  ETPharma.com

Pfizer, Cipla ink exclusive marketing, distribution pact for 4 brands - ETPharma.com

Click here to get full coverage on Cipla, Sun Pharma recall drugs in US - ETPharma.com

Cipla, Sun Pharma recall drugs in US  ETPharma.com

Cipla, Sun Pharma recall drugs in US - ETPharma.com

Click here to get full coverage on Cipla CEO Umang Vohra exits after a decade; Achin Gupta to lead next phase - People Matters - HR News

Cipla CEO Umang Vohra exits after a decade; Achin Gupta to lead next phase  People Matters - HR News

Cipla CEO Umang Vohra exits after a decade; Achin Gupta to lead next phase - People Matters - HR News

Click here to get full coverage on Pfizer Secures Vyndamax Patent Till 2031, Settles Disputes with Cipla, Hikma, Dexcel Pharma - Medical Dialogues

Pfizer Secures Vyndamax Patent Till 2031, Settles Disputes with Cipla, Hikma, Dexcel Pharma  Medical Dialogues

Pfizer Secures Vyndamax Patent Till 2031, Settles Disputes with Cipla, Hikma, Dexcel Pharma - Medical Dialogues

Click here to get full coverage on Buy Cipla; target of Rs 1550: ICICI Securities - TradingView

Buy Cipla; target of Rs 1550: ICICI Securities  TradingView

Buy Cipla; target of Rs 1550: ICICI Securities - TradingView

Click here to get full coverage on Stocks to Watch Today: HDFC Bank, EMS, ICICI Bank, Cipla, Aurobindo Pharma, Bharat Wire Ropes, Lupin,... - Moneycontrol.com

Stocks to Watch Today: HDFC Bank, EMS, ICICI Bank, Cipla, Aurobindo Pharma, Bharat Wire Ropes, Lupin,...  Moneycontrol.com

Stocks to Watch Today: HDFC Bank, EMS, ICICI Bank, Cipla, Aurobindo Pharma, Bharat Wire Ropes, Lupin,... - Moneycontrol.com

Click here to get full coverage on Cohance Lifesciences taps former Cipla chief Umang Vohra to revive growth, shares jump 20% - Moneycontrol.com

Cohance Lifesciences taps former Cipla chief Umang Vohra to revive growth, shares jump 20%  Moneycontrol.com

Cohance Lifesciences taps former Cipla chief Umang Vohra to revive growth, shares jump 20% - Moneycontrol.com

Click here to get full coverage on U.S. FDA issues two observations to Cipla arm InvaGen’s U.S. facility - The Hindu

U.S. FDA issues two observations to Cipla arm InvaGen’s U.S. facility  The Hindu

U.S. FDA issues two observations to Cipla arm InvaGen’s U.S. facility - The Hindu

Click here to get full coverage on Cipla USA recalls Nilotinib anti-cancer capsules over manufacturing issue: USFDA - The Economic Times

Cipla USA recalls Nilotinib anti-cancer capsules over manufacturing issue: USFDA  The Economic Times

Cipla USA recalls Nilotinib anti-cancer capsules over manufacturing issue: USFDA - The Economic Times

Click here to get full coverage on Cipla to expand Fall River facilities, hiring - Providence Business News

Cipla to expand Fall River facilities, hiring  Providence Business News

Cipla to expand Fall River facilities, hiring - Providence Business News

Click here to get full coverage on Cipla weighs shifting Lanreotide production amid Rodopi FDA compliance hurdle - ETPharma.com

Cipla weighs shifting Lanreotide production amid Rodopi FDA compliance hurdle  ETPharma.com

Cipla weighs shifting Lanreotide production amid Rodopi FDA compliance hurdle - ETPharma.com

Click here to get full coverage on Cipla Receives Two Form 483 Observations Following U.S. FDA Inspection of Goa Plant - scanx.trade

Cipla Receives Two Form 483 Observations Following U.S. FDA Inspection of Goa Plant  scanx.trade

Cipla Receives Two Form 483 Observations Following U.S. FDA Inspection of Goa Plant - scanx.trade

Click here to get full coverage on Cipla Expands Fall River Operations in USA - citybiz

Cipla Expands Fall River Operations in USA  citybiz

Cipla Expands Fall River Operations in USA - citybiz

Click here to get full coverage on Pfizer and Cipla announce partnership - The Hindu

Pfizer and Cipla announce partnership  The Hindu

Pfizer and Cipla announce partnership - The Hindu

Click here to get full coverage on Cipla debuts weight-loss drug Tirzepatide second brand Yurpeak - ETPharma.com

Cipla debuts weight-loss drug Tirzepatide second brand Yurpeak  ETPharma.com

Cipla debuts weight-loss drug Tirzepatide second brand Yurpeak - ETPharma.com

Click here to get full coverage on Cipla to form JV with Kemwell Biopharma; share price down marginally - Moneycontrol.com

Cipla to form JV with Kemwell Biopharma; share price down marginally  Moneycontrol.com

Cipla to form JV with Kemwell Biopharma; share price down marginally - Moneycontrol.com

Click here to get full coverage on cipla s us product supply delayed due to fda inspection - ICICI Direct

cipla s us product supply delayed due to fda inspection  ICICI Direct

cipla s us product supply delayed due to fda inspection - ICICI Direct

Click here to get full coverage on CIPLA Outlook for the Week (May 04, 2026 – May 08, 2026) - Equitypandit

CIPLA Outlook for the Week (May 04, 2026 – May 08, 2026)  Equitypandit

CIPLA Outlook for the Week (May 04, 2026 – May 08, 2026) - Equitypandit

Click here to get full coverage on Cipla tanks 20% so far in CY 2026; hits over 2-year low in firm market - Business Standard

Cipla tanks 20% so far in CY 2026; hits over 2-year low in firm market  Business Standard

Cipla tanks 20% so far in CY 2026; hits over 2-year low in firm market - Business Standard

Click here to get full coverage on Cipla launches nationwide ‘Win Over Weight’ campaign to tackle obesity stigma - Campaign Brief Asia

Cipla launches nationwide ‘Win Over Weight’ campaign to tackle obesity stigma  Campaign Brief Asia

Cipla launches nationwide ‘Win Over Weight’ campaign to tackle obesity stigma - Campaign Brief Asia

Click here to get full coverage on Cipla Launches Afrezza in India: Revolutionizing Diabetes Care with Needle-Free Inhaled Insulin - Medical Dialogues

Cipla Launches Afrezza in India: Revolutionizing Diabetes Care with Needle-Free Inhaled Insulin  Medical Dialogues

CIPLA

Price Chart

Key Statistics

Technicals

About CIPLA

Latest News

Cipla Receives U.S. FDA Approval for First AB-Rated Generic of Ventolin® HFA - Yahoo Finance

Cipla strengthens US portfolio with the launch of generic Saxenda® (Liraglutide Injection) for weight management therapy - PR Newswire

India's Cipla posts steeper-than-expected quarterly profit slump on tumour drug supply crunch - Reuters

Advanced Charts

Top Gainers

Top Losers